GRTS - Gritstone Oncology GAAP EPS of -$0.35 revenue of $3.02M
- Gritstone Oncology press release ( NASDAQ: GRTS ): Q3 GAAP EPS of -$0.35.
- Revenue of $3.02M (+15.7% Y/Y).
- Cash, cash equivalents, marketable securities and restricted cash were $151.8 million as of September 30, 2022, compared to $223.5 million as of December 31, 2021.
For further details see:
Gritstone Oncology GAAP EPS of -$0.35, revenue of $3.02M